Clinuvel Pharmaceuticals Limited
About
9.13AUD+0.17 +1.90%
Closed • Updated at 04:37 GMT+00:00Market Cap$323.64M
P/E Ratio14.17
Volume70.2K
Beta0.38
RSI48.02
Gross Margin63.71%
Clinuvel Pharmaceuticals Limited — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 28 2026
CLINUVEL update on Level II ADR upgrade, Nasdaq uplist
Apr 27 2026
FDA relaxes SCENESSE postmarketing requirement
Apr 24 2026
CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study
Apr 24 2026
Final EMA scientific advice for pivotal Phase III vitiligo
Mar 27 2026
CLINUVEL's global programs showcased at AAD
Recent Videos
Cómo comprar acciones de Clinuvel Pharmaceuticals Ltd (CUV.ASX)
Apr 06, 2026
Half Year Results for FY2026 — Investor Webinar
Mar 04, 2026
CLINUVEL Annual General Meeting 2025
Oct 20, 2025
CLINUVEL PHARMACEUTICALS LTD (ASX: CUV) | Daily Analysis Video Report
Sep 12, 2025
Community Chat
Ask AI
Try asking